PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩0 per share · Prices as of the 2026-10-02 close
Shinpoong has posted an operating loss every year since exiting corrugated linerboard manufacturing for a paper distribution model, but non-operating items have pushed recent annual and quarterly net income into positive territory.
The company posted an operating loss in all four fiscal years from 2022 to 2025, with operating margin ranging between -22.4% and -9.5%.
Owner net income swung from losses in 2022–2023 to modest profits in 2024–2025, and jumped to KRW 6.9 billion in Q2 2026, markedly higher than preceding quarters.
The debt ratio fell sharply from 45.4% in 2023 to 3.9% in 2025, indicating a rapid improvement in the balance sheet.
The company previously disclosed that it halted production after its Pyeongtaek plant was subject to compulsory land acquisition, and now operates a paper distribution business without in-house manufacturing.
The company has explicitly disclosed that it has no ownership or business connection to the similarly named Shinpoong Pharm., warranting caution against confusion.
Shinpoong (002870) was founded in 1958 and for many years operated primarily as a manufacturer of corrugated linerboard (packaging paper).
The company disclosed that production was halted after its plant site in Pyeongtaek, Gyeonggi Province was subject to compulsory acquisition by the Korea Land & Housing Corporation (LH) under the Pyeongtaek International Zone development designation, with demolition proceeding afterward.
Following this, the company shut down its own manufacturing facilities and restructured around a paper distribution business, according to its own disclosure.
The company has also explicitly stated that it does not handle corrugated board itself, clarifying that it has no direct link to the corrugated-board shortage narrative that circulated during the pandemic-era courier packaging boom.
Under Korea Exchange classification the stock sits in the KOSPI distribution sector, while the FICS industry classification places it in paper and wood products. Annual revenue in the range of roughly KRW 20–27 billion places it among the smaller listed names in its category.
The company has directly disclosed that, despite the similar name, it has no equity or business relationship with Shinpoong Pharm., which investors should keep in mind to avoid confusion.
With the business model having shifted from manufacturing toward distribution, results are likely driven more by trading margins and inventory management efficiency than by raw material cost advantages or captive production capacity.
| Quarter | Revenue | Operating profit | Op. margin |
|---|---|---|---|
| 2025Q2 | ₩6.4B | -₩500M | −7.3% |
| 2025Q3 | ₩6.3B | -₩400M | −5.8% |
| 2025Q4 | ₩5.7B | -₩600M | −10.2% |
| 2026Q1 | ₩6B | -₩600M | −9.4% |
| 2026Q2 | ₩6.8B | -₩600M | −9.0% |
| Year | Revenue | Operating profit | Net income (parent) | Op. margin | ROE | Debt-to-equity |
|---|---|---|---|---|---|---|
| 2022 | ₩18.8B | -₩4.2B | -₩7.5B | −22.4% | −9.4% | 36.5% |
| 2023 | ₩26.9B | -₩4B | -₩6.5B | −14.9% | −9.0% | 45.4% |
| 2024 | ₩22.8B | -₩4.4B | ₩300M | −19.2% | 0.4% | 5.0% |
| 2025 | ₩24.2B | -₩2.3B | ₩2B | −9.5% | 2.7% | 3.9% |
Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-08-23
Annual revenue moved without a clear trend, rising from KRW 18.78 billion in 2022 to KRW 26.90 billion in 2023, falling to KRW 22.78 billion in 2024, then edging up to KRW 24.23 billion in 2025.
Operating results were negative in all four years: -KRW 4.20 billion in 2022 (operating margin -22.4%), -KRW 4.00 billion in 2023 (-14.9%), -KRW 4.37 billion in 2024 (-19.2%), and -KRW 2.29 billion in 2025 (-9.5%), with the loss narrowing most in 2025.
Owner net income followed a different path: losses of -KRW 7.54 billion in 2022 and -KRW 6.50 billion in 2023 gave way to profits of +KRW 0.31 billion in 2024 and +KRW 2.00 billion in 2025, suggesting non-operating items drove the shift.
Operating cash flow also swung from large outflows of -KRW 3.92 billion in 2022 and -KRW 17.53 billion in 2023 to inflows of +KRW 2.97 billion in 2024 and +KRW 2.66 billion in 2025.
On a quarterly basis, operating losses persisted for five straight quarters, from -KRW 0.47 billion in Q2 2025 to -KRW 0.61 billion in Q2 2026.
Owner net income, however, registered +KRW 0.36 billion in Q2 2025, +KRW 0.96 billion in Q3 2025, -KRW 0.01 billion in Q4 2025, and +KRW 0.85 billion in Q1 2026, before jumping to +KRW 6.89 billion in Q2 2026 — a sharp expansion from prior quarters that, given the continuing operating loss in the same quarter, appears attributable to non-operating factors.
The sum of owner net income across the most recent four quarters (Q3 2025–Q2 2026) came to KRW 8.68 billion, but the wide quarter-to-quarter variance warrants caution against over-interpreting any single quarter.
The KOSPI distribution and paper-and-wood classification that Shinpoong falls under is closely linked to domestic demand for packaging and printing paper, with the sector cycle tracking downstream packaging demand from e-commerce and logistics.
However, since the company has disclosed its shift away from in-house corrugated board manufacturing toward distribution, its business model and margin structure differ from vertically integrated large paper makers that retain their own linerboard and box production capacity.
During the early COVID-19 period in 2020, a corrugated-board shortage tied to surging courier volumes drove a rally across paper-sector stocks, and Shinpoong (then Shinpoong Paper) was swept into that theme due to the similarity of its name, though the company clarified via disclosure that it does not handle corrugated board.
This episode illustrates how sector-wide themes do not always align with individual company fundamentals.
In a distribution-centered model, raw paper price swings, logistics costs, and inventory management efficiency have a direct bearing on margins, and the company may be structurally disadvantaged on cost control relative to competitors with captive production.
As a small-cap name within KOSPI, share price volatility tied to trading volume and supply-demand factors can also be relatively pronounced, a characteristic worth noting for this sector and stock.
Public disclosures reviewed did not include company-specific revenue targets, new capacity investment plans, or product launch schedules that would constitute forward guidance.
Based on confirmed financial data through the latest period, the operating loss has continued for five consecutive quarters, meaning clear profitability improvement in the core distribution business has not yet materialized.
Net income, by contrast, has stayed positive in recent quarters on the back of non-operating factors, and notably expanded sharply in Q2 2026 relative to the prior quarter.
The nature of this non-operating item and whether it is likely to recur are matters that would need to be confirmed through the footnotes of upcoming quarterly and annual reports.
The sharp decline in the debt ratio from 45.4% in 2023 to 3.9% in 2025 could be read as a positive signal for balance sheet health, but whether this reflects a structural change in operations or a one-time resolution of specific asset or liability items warrants further confirmation.
Going forward, the trajectory of results should be assessed along two axes together: whether the operating loss continues to narrow, and whether the non-operating gains prove recurring or one-off.
The current share price trades below the company's net asset value, placing the price-to-book ratio in a sub-1x range. This should be interpreted alongside the fact that operating results have remained in loss for multiple consecutive years and that recent net income has been driven by non-operating factors.
On the dividend front, no distribution was made in the most recent fiscal year, meaning market attention centers more on the scale of net assets than on shareholder returns.
The recent shift from net losses to net profits could be read as constructive for valuation metrics, but caution is warranted against annualizing or simplistically comparing a quarter like Q2 2026, where profit expanded sharply versus the prior quarter.
Ultimately, valuation for this stock sits in a range that can be read differently depending on two variables: whether core operating profitability recovers, and whether the non-operating gains prove repeatable.
PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-08-23
The debt ratio fell sharply from 45.4% in 2023 to 3.9% in 2025, marking a rapid improvement in financial health. Total liabilities over the same period dropped from KRW 32.55 billion to KRW 2.84 billion.
Operating cash flow also turned positive in both 2024 and 2025, a contrast to the large cash outflows seen in 2022–2023.
Owner net income turned from losses in 2022–2023 to profits in 2024–2025, and profitability has continued into recent quarters. Net income expanded sharply in Q2 2026 versus the prior quarter, bringing the four-quarter trailing sum to KRW 8.68 billion. Since this profitability stems from non-operating factors, its durability needs to be separately verified.
The current share price trades below the company's net asset value, which some observers may view as a supporting factor from an asset perspective. The company has a history of holding a large manufacturing site, which draws attention from investors focused on asset composition. This is presented as a factual observation, not a value judgment.
The company posted an operating loss in all four years from 2022 to 2025, and the operating loss continued through all five confirmed quarters from Q2 2025 to Q2 2026. Even with recent improvement, the operating margin remains in negative territory. Recovery in core business profitability has not yet been confirmed.
The recent return to net profit occurred against a backdrop of continuing operating losses, suggesting results are being driven by non-operating factors. In particular, the profit expansion in Q2 2026 cannot rule out a one-off character, given that the operating loss persisted in the same period. The recurrence of such gains remains uncertain at this stage.
Annual revenue has fluctuated between roughly KRW 20 billion and KRW 27 billion without clear growth momentum. Having shifted from manufacturing to distribution, the company may face structural constraints on cost control given the loss of a captive production base. As a small-cap stock, price volatility tied to trading and supply-demand dynamics is also a point worth noting.
Operating losses have continued even after the shift from manufacturing to distribution, leaving uncertainty over whether the current business model can achieve sustainable profitability. Given the distribution margin structure, results may be sensitive to swings in raw material prices or logistics costs.
A model focused on distribution without in-house production may offer relatively weaker buffering against economic cycles.
Recent net profits appear to have been formed by non-operating factors amid continuing operating losses. Whether such items will recur each quarter cannot be confirmed with currently available information.
If future reports do not clarify the specific nature of these items, uncertainty will remain in interpreting results.
There is a history of the stock experiencing sharp swings after being mistaken for a corrugated-board theme play due to the similarity of its former name, which the company addressed directly through disclosure. As a small-cap stock, price volatility can be amplified by float and trading volume. Price movements driven by supply-demand factors unrelated to business fundamentals warrant attention.
The Q3 2026 report should be checked to see whether the operating loss persists and whether the net income surge seen in Q2 2026 was one-off or has recurred.
It is worth monitoring DART for any follow-up disclosure clarifying the specific nature of the non-operating items (e.g., asset disposal, equity-method gains, valuation gains).
The FY2026 annual report should be reviewed to reconfirm whether annual operating results have improved and whether the debt ratio trend continues.
Disclosures around the annual general shareholders' meeting should be checked for any additional statements on dividend policy or business direction.
Shinpoong is a small-cap listed company that exited corrugated linerboard manufacturing and shifted to a paper distribution business, posting operating losses in all four fiscal years from 2022 through 2025 and across all five confirmed quarters.
Owner net income, however, turned positive in 2024 and 2025 and has remained positive in recent quarters, with a particularly sharp expansion in Q2 2026 that brought the trailing four-quarter sum to KRW 8.68 billion.
Because this profitability emerged alongside continuing operating losses, it appears attributable to non-operating factors, and its sustainability requires further confirmation. On the balance sheet side, the debt ratio showed clear improvement, falling from 45.4% in 2023 to 3.9% in 2025.
The company has directly disclosed that it has no relationship with the similarly named Shinpoong Pharm., a point investors should keep in mind to avoid confusion.
Overall, the two key variables for interpreting future results will be whether core operating profitability recovers and whether the non-operating gains prove recurring.
Report written 2026-09-05 · Data as of 2026-09-04
This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.